Abstract
• Patients with advanced testicular cancer receive cisplatin-based chemotherapy with a high rate of cure. • Cisplatin-based chemotherapy increases risks of acute vascular complications among testicular cancer survivors. • Cisplatin-based chemotherapy increases cardiovascular disease risk factors and cardiovascular disease among testicular cancer survivors. • Long-term management of cardiovascular risk factors and cardiovascular disease in testicular cancer survivors is recommended.